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Abstract
Background: Sugar moieties of gonadotropins play no primary role in receptor binding but they
strongly affect their circulatory half-life and consequently their in vivo biopotencies. In order to
relate more precisely hepatic trapping of these glycoproteic hormones with their circulatory half-
life, we undertook a comparative study of the distribution and elimination of porcine LH (pLH) and
equine CG (eCG) which exhibit respectively a short and a long half-life. This was done first by
following half-lives of pLH in piglets with hepatic portal circulation shunted or not. It was expected
that such a shunt would enhance the short half-life of pLH. Subsequently, scintigraphic imaging of
both 123I-pLH and 123I-eCG was performed in intact rats to compare their routes and rates of
distribution and elimination.
Methods: Native pLH or eCG was injected to normal piglets and pLH was tested in liver-shunted
anæsthetized piglet. Blood samples were recovered sequentially over one hour time and the
hormone concentrations were determined by a specific ELISA method. Scintigraphic imaging of 123I-
pLH and 123I-eCG was performed in rats using a OPTI-CGR gamma camera.
Results: In liver-shunted piglets, the half-life of pLH was found to be as short as in intact piglets (5
min). In the rat, the half-life of pLH was also found to be very short (3–6 min) and 123I-pLH was
found to accumulate in high quantity in less than 10 min post injection at the level of kidneys but
not in the liver. 123I-eCG didn't accumulate in any organ in the rats during the first hour, plasma
concentrations of this gonadotropin being still elevated (80%) at this time.
Conclusion: In both the porcine and rat species, the liver is not responsible for the rapid
elimination of pLH from the circulation compared to eCG. Our scintigraphic experiments suggest
that the very short circulatory half-life of LH is due to rapid renal trapping.
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Background
Glycoprotein hormones (Luteinizing Hormone LH, Folli-
cle-Stimulating Hormone FSH, Chorionic Gonadotropin
CG and Thyroid-Stimulating Hormone TSH) are com-
prised of two dissimilar, non-covalently bound glycopro-
teic subunits, named α and β and their 1:1 association is
mandatory for hormonal activity. The α-subunit is com-
mon to all of them and it is encoded by an unique gene
whereas the different β-subunits confer hormonal specifi-
city to each αβ heterodimer.
It has been known for a long time that the sugar moieties
of gonadotropins play no primary role in receptor binding
affinity or specificity but that they strongly affect their cir-
culatory half-life and consequently their in vivo biopoten-
cies. Indeed, when completely deglycosylated,
glycoprotein hormones exhibit neither in vivo nor in vitro
bioactivity but they retain their ability to specifically bind
to their receptors and so act as antagonists [1]. Carbohy-
drate moieties of glycoprotein hormones are thus not
required for binding to their cognate receptors but they
play a direct or indirect role in signal transduction. Desia-
lylation of hCG, eCG or FSH leads to a dramatic decrease
in their in vivo bioactivity, whereas in vitro bioactivity is
unchanged or even increased [2]. Therefore, the terminal
sialic acid residues of these hormones are important for
their survival in circulation and desialylation which leads
to a drop in their circulatory half-life also results in an
almost complete loss of in vivo bioactivity.
If one aims at increasing the in vivo activity of glycopro-
tein hormones, it is essential to understand the mecha-
nisms of removal of these hormones from the circulation
and to identify the structural features implicated in that
process. It is generally postulated that desialylated hor-
mones having galactose exposed after sialic acid removal
are captured by the liver by binding to the membrane
galactose receptor of Ashwell [3], and that LH possessing
sulfated terminal residues are extracted from blood flow
by hepatic reticuloendothelial sulfated-GalNAc receptor
of Baezinger [4]. In keeping with this view, pituitary LH
from different species which are poorly or not sialylated at
all, exhibit very short half-life compared to FSH and even
more compared to CG.
Nevertheless, studies from several groups in the seventies
suggested that kidneys could be implicated in gonadotro-
pin removal from blood. Indeed, Gay [5] and De Kretser
et al [6] showed that upon nephrectomy, half-life of LH
and FSH were increased. In addition, after injection of 3H-
ovine LH, Ascoli et al [7] found that the radioactivity was
mainly recovered in kidneys and urine.
Therefore, in order to get a better understanding of the
mechanism of gonadotropin removal from circulation,
we undertook a comparative pharmacokinetic study of
pLH and eCG. Porcine LH was chosen because of its pre-
viously recognized very short half-life (only a few min-
utes) [7] while the well known long half-life of eCG (6
hours to 1 day or more, depending on the species and
methods used) [8,9] has been exploited for more than
half a century in the induction of follicular growth in
domestic animals.
We first compared the plasma kinetics of the two hor-
mones in piglets, and confirmed the short half-life of pLH
in its own species. Subsequently, we studied the influence
of a shunt of the hepatic portal vein on the half-life of por-
cine LH. Finally, in order to explore directly the distribu-
tion/elimination routes of gonadotropins, we undertook
a scintigraphic imaging study with the two 123I-labelled
hormones. We chose the rat as animal model, in order to
get whole body imaging with the gamma camera used. To
our knowledge, this is the first 123I scintigraphic imaging
study of gonadotropin pharmacokinetics.
Methods
Animals
Male Meishan piglets, around 15 kg, were bred in the
experimental pigsty of the INRA Centre in Nouzilly. Nor-
mal adult male and female Wistar male rats aged 52 days,
mean weight 200 g, were obtained from the Small Animal
Breeding Facility of the Laboratory.
All the procedures used in the experiments presented in
this paper were in compliance with the European Com-
munity Council Directive of November 24 1986 (86/609/
EEC).
pLH and eCG plasma kinetics in normal piglets
Piglets were halothane-anæsthetized before jugular and
carotid catheterization. Blood samples were removed via
the jugular cannula just before and every 5 min over a 1 h
period after administration through the carotid of 1,5 mg
of either pLH or eCG in saline. These samples were centri-
fuged 10 minutes at 3000 g at 4°C and the hormones con-
centrations were determined in plasma by specific
competition enzyme-linked immunosorbent assays
(ELISA) for eCG [10] and pLH [Lecompte F and Com-
barnous Y; unpublished]. Briefly, the pLH competitive
ELISA was set-up using pLH from Dr Hennen's Laboratory
[11] and rabbit anti-pLH serum (ref 61977) kindly given
by Dr Jean Pelletier (INRA, Nouzilly). This antibody has
been shown to be specific for LH in RIA with less than 1%
cross-reaction with FSH [12]. The microtiter plates were
coated with 10 ng pLH/100 µl at pH 9.6 overnight at 4°C
and after washing, 50 µl of samples (reference or
unknown) were added together with 50 µl antiserum
diluted 1/80,000. After 4 hours at 4°C, the wells were
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Page 3 of 8
(page number not for citation purposes)
conjugated anti-rabbit serum (BioRad, Marnes-la-
Coquette, France) were added. After 1 hour at 4°C, the
wells were emptied and washed three times and 100 µl of
SureBlue™ substrate (KPL, Gaithersburg, Md, USA) were
added and incubation was carried out for 30 minutes at
room temperature in the dark. Finally, the reaction was
stopped with 50 µl H2SO4 and the optical densities of
each well at 450 nm were recorded on a SpectraCount
spectrophotometer (Packard, Chicago, Il USA) and con-
centrations were calculated using the Packard RIASmart™
package.
Pharmacokinetic data were analyzed by non-linear fitting
to exponential decay equation using Graph-Pad Prism™
version 2.0 package (Intuitive Software for Science, San
Diego USA).
Kinetics of pLH in liver-shunted piglets
An halothane-anæsthetized piglet was catheterized in the
right jugular vein and the hepatic portal vein and the cava
vein were also catheterized and connected via a Y-tube to
the jugular vein catheter so that veinous circulation to the
liver is totally shunted. The hepatic vascular pedicle was
also clamped, so that no more vascular exchanges with
liver was possible. Hormone injection, blood collection,
ELISAs and analyses were performed as described above.
Kinetics of pLH and eCG in normal rats
Five anaesthetized male rats received 20 µg pLH in the tail
vein and four others received 20 µg eCG. Blood was with-
drawn on heparin from the jugular vein. The samples were
treated as previously described. The animals injected with
pLH were sacrificed and urine aspirated from the bladder
one hour post-injection. The animals injected with eCG
were placed in a metabolic cage between two blood with-
drawals in order to collect emitted urine and if no urine
could be collected in this way, aspiration from bladder
was performed as above. Hormonal concentrations in
urine were determinated by ELISA as above.
Glycoprotein Hormones radiolabeling
Porcine LH (pLH DKL-D110; 3.0 × NIH-LH-P1) and eCG
(eCG FL652; 6700 IU/mg) were purified in our laboratory
[13,14] and 10 mg/ml stock solutions were prepared in 50
mM phosphate buffer pH 7.4. Radioiodination with 123I
was performed using the Iodo-Gen® method [15] using
[123I] sodium iodide (71.4 TBq/mg i.e. 8.78 × 1018 Bq/mol
iodide; no carrier added) from Cis-bio international (Gif-
sur-Yvette, France). Briefly, 96–110 MBq 123I in 100 µl 50
mM phosphate buffer pH = 7.4 were added to an Eppen-
dorf tube precoated with 20 µg Iodo-Gen® (1,3,4,6-tetra-
chloro-3α,6α-diphenylglycoluril, Pierce). Ten µl (100 µg,
2.27 × 10-9 mole eCG or 3.57 × 10-9 mole pLH) were then
added to this tube, and the reaction was allowed to pro-
ceed for 10 min on ice. Then, the mixture was applied
onto a sephadex G-25 column (PD-10, Pharmacia, Upp-
sala, Sweden) pretreated with the corresponding hor-
mone to saturate non-specific sites, and eluted with saline
solution to separate the labeled hormone from unconju-
gated 123I. The labeling efficiencies were 26–28% and after
removal of free iodide, the final specific activities for the
two hormones were approximately 0,3 MBq/µg which are
similar to those reached for 123I-IL-8 [16]. The specific
activities correspond to I/protein molar ratios of 1/1104
for 123I-pLH and 1/738 for 123I-eCG.
Biodistribution of radiolabeled hormones by gamma 
camera imaging
The rats were anaesthetized by halothane inhalation (1–
3% in air influx at 1 l/min), placed prone on the gamma
camera, and then immediately received a single IV injec-
tion of either 123I-pLH (2 rats), 123I-eCG (3 rats) or free
123I Na (3 rats).
After IV injection, dynamic 1-minute images were
recorded over the first 30 minutes and 2-minute images
after 1, 2, 3, 4, 5 and 6 hours for both pLH and eCG. In
the case of eCG, images were also recorded after 7, 8, 9
and 10 hours. The animals were returned to their cage
after each scintigraphy, and re-immobilized by slight
halothane anæsthesia for the following one.
Images were recorded using a gamma OPTI-CGR camera
equipped with low-energy high resolution parallel colli-
mator. The energy peak was centred at 158 KeV (123I
energy peak) with a 15% window. Planar images were
acquired into 128 × 128 pixels matrix with a dedicated
computer system for digital display and analysis (TIM
512; Motorola). After acquisition of 50000–100000
counts, the images were digitally stored in a 128 × 128
matrix. The scintigraphic results were analysed quantita-
tively by drawing regions of interest (ROI) created for
heart, kidney, liver, and all body. The count rates recorded
within these regions were used after correction for radio-
active decrease, to calculate the percentage of radioactive
hormone in each organ. One or two flasks with known
123I doses were placed beside the animal for camera
calibration.
Half-life of 123I-pLH was determined by following emis-
sion at heart level.
Results
Kinetics of pLH and eCG in normal piglets
As shown on figure 1, plasma pLH concentrations meas-
ured by EIA decreased rapidly after injection in the piglet.
On the contrary, 80% plasma eCG was still present one
hour p.i. The half-life of pLH was found to be 4.50 min
(95%CL 3.68–5.81).Reproductive Biology and Endocrinology 2003, 1 http://www.RBEj.com/content/1/1/64
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Kinetics of pLH in liver-shunted piglets
As illustrated in figure 1, plasma pLH elimination is not
significantly affected when the hepatic veinous circulation
is shunted towards jugular vein. The half-life of pLH was
found to be 5.19 min (95%CL 3.70–8.64) and as in intact
animals, 80 % plasma eCG was still present one hour p.i.
This suggests a very limited role of the liver if any in the
fast elimination of porcine LH from circulation.
Kinetics of pLH and eCG in normal rats
Kinetics of pLH elimination in the rat after IV injection
was quite similar to that observed in the piglet. The half-
life of pLH was found to be 6.17 min (95%CL 5.20–7.58).
For eCG, plasma concentrations were still elevated one
hour p.i. both in the rat (80%, figure 2) and the piglet
(85%, figure 1).
Hormonal recovery of pLH in urine one hour after injec-
tion was very low: only 1.2 to 2.5 ng pLH (less than
0,012% of the injected dose) were recovered in urine as
measured by ELISA. In the case of eCG, 86 ng and 332 ng
were recovered for two animals tested, which represented
0.4% and 1.7% of the injected dose. Therefore, only a tiny
amount of gonadotropin was recovered in urine over a 1-
hour period of time after injection whatever its half-life in
circulation is short (pLH) or long (eCG).
Biodistribution of radiolabeled hormones by gamma 
camera imaging
Free 123Iodine
After IV injection, free iodine was observed in the vascular
bed, as shown by the visualization of lungs and heart (fig-
ure 3; right panel). It is rapidly extracted (15 minutes p.i.)
by stomach, intestine and thyroid gland. The radioisotope
is also eliminated in urine, the urinary bladder being
imaged 15 minutes postinjection without any observable
kidney accumulation.
Radioiodinated pLH
Immediatly after IV injection, radiolabeled pLH was seen
in highly vascularized organs, such as heart, lungs and
liver (figure 3; left panel). They exhibited a rapid clearance
in these organs and we determined the t1/2 of 123I-pLH by
following its emission in blood at heart level making the
assumption that there is no binding of LH in heart (figure
4). A t1/2 value of 2.64 min (95%CL 2.26–3.18) for 123I-
pLH was calculated. Accumulation of radioiodinated pLH
occurred in the kidneys: 14% of the total injected dose
was recovered in the left kidney only ten minutes after
injection. When whole body scintigraphic images were
examined (figure 3), it appeared that all radioactivity was
localized in the renal tract in less than 10 minutes p.i.,
with very low activity observed in urinary bladder. In the
liver, radioactivity appeared fugaciously, and disappeared
very rapidly. No radioactivity was present in stomach and
intestine until 30 minutes p.i., and thyroid became visible
only after 60 minutes p.i. At this time, the different
Half-life of porcine LH in intact and liver-shunted piglets by  ELISA Figure 1
Half-life of porcine LH in intact and liver-shunted pig-
lets by ELISA. Hepatic portal vein and vena cava of anes-
thetized female piglets were derived towards jugular vein as 
to completely suppress removal of gonadotropins from cir-
culation by the liver. Control animals were sham-operated. 
Blood samples were continuously taken from contralateral 
jugular vein before and over 1 hour after injection. Hormone 
concentrations were measured by ELISA. Half-life of pLH in 
the two animal models was determined by non-linear regres-
sion of relative intensities as a function of time.
Half-life of porcine LH and equine CG in rats by ELISA Figure 2
Half-life of porcine LH and equine CG in rats by 
ELISA. Halothane-anaesthetized rats aged 52 days, received 
20 µg pLH or eCG in the tail vein. Blood was withdrawn on 
heparin from the jugular vein. Hormone concentrations were 
measured by ELISA. Half-life of pLH was determined by non-
linear regression of concentrations as a function of time.Reproductive Biology and Endocrinology 2003, 1 http://www.RBEj.com/content/1/1/64
Page 5 of 8
(page number not for citation purposes)
activities observed for the left and the right kidneys could
be ascribed to stomach superimposition over kidney. No
significant accumulation of radioactivity in genitals nor in
any other extravascular compartment was observed.
Radioiodinated eCG
Immediately after injection, radiolabeled eCG was seen in
the heart and lungs, with a level of activity remaining
unchanged over 1 hour (figure 3; central panel) before
slowly decreasing until 10 hours (not shown). At this
time, these organs still exhibited about 10% of the
injected radioactivity dose. Intensity of 123I emission was
not superior at the level of liver compared to the lungs,
indicating that there was no significant fixation in this
organ. No radioactivity was observed in the kidneys, nor
in the urinary bladder. No other extravascular
compartment accumulated the radiolabeled compound,
neither thyroid gland nor genitals.
Discussion
The liver has been shown to bind glycoproteins through
its hepatocyte asialoglycoprotein receptor by recognizing
terminal Gal residues after removal of sialic acid from
their SiaAc-Gal-GlcNAc-Man complex carbohydrate
chains. In contrast to FSH and CG, LH from different
species bear very low amounts of sialic acid and bear sul-
fated-GalNAc-GlcNac-Man instead. Specific receptors for
this type of chain has been described in liver [4] and they
have been proposed to be responsible for the very fast
elimination of pituitary native LH compared to the sia-
lylated recombinant LH produced in CHO cells.
Scintigraphic images of 123I-pLH, 123I-eCG and free 123I distribution in male rats after IV injection Figure 3
Scintigraphic images of 123I-pLH, 123I-eCG and free 123I distribution in male rats after IV injection. Left panel: 123I-
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Native pituitary LH from various species disappear rapidly
from the circulation and their t1/2 during this first phase of
elimination have been found to be approximately 15 min
for hLH in the human [17,18] and as low as low as 1.2
min for bovine LH in the rat [19]. In agreement with these
previous data, we found that the initial phase of elimina-
tion of porcine LH from the circulation in the pig and rat
is extremely fast. In pig, a half-life (t1/2) of less than 5 min-
utes was observed for pLH despite we injected the hor-
mone in arteria to avoid hepatic first-pass effect. Since
pLH is the homologous hormone, it is likely that this low
t1/2 value is meaningful. We expected that the elimination
of injected pLH would be slower when hepatic portal cir-
culation was totally derived to vena cava and jugular vein
since receptors for sulfated-GalNAc-GlcNac-Man are
present in the liver [4]. To our surprise, we found that the
initial phase of pLH elimination was not significantly
changed by liver shunt and its t1/2 value remained at 5
minutes.
In rat, the t1/2 of pituitary pLH determined by ELISA after
bolus injection (6 min) is quite similar to that found in
pig (5 min) and in rat as in pig, eCG did not exhibit any
fast elimination phase. The similarity of t1/2 of pLH in pig
and rat prompted us to determine more precisely the
route of fast elimination of pLH in the rat which is more
amenable to scintigraphic imaging than the pig.
Only about one molecule out of 1000 is radioiodinated in
123I-pLH solution and thus radioactive molecules are
most likely mono-iodinated on their tyrosine residue in
position 21 of their α-subunit [20]. The substitution of
the Tyr α-21 residue of pLH by two cold iodine atoms
leads to a moderate decrease in the in-vivo bioactivity of
pLH in rats [20]. The substitution by only one iodine
atom is expected to have an even lower effect on pLH bio-
activity indicating that its mono-iodination does not
modify its rate of elimination and consequently does not
change its route of elimination.
We determined the t1/2 of 123I-pLH by following its emis-
sion in blood at heart level making the assumption that
there is no binding of LH in heart. The found t1/2 of 2.6
min is consistent with the values of 1.2 min for 125I-bLH
[19] and 6.2 min for unlabeled pLH (this work) in the rat
and confirms the very fast elimination of LH molecules
from the circulation. The slightly lower t1/2  values
obtained with radioiodinated LHs could arise from pref-
erential iodination of basic isoforms which are known to
exhibit shorter half-life than acidic isoforms. Alterna-
tively, it could be that acidic isoforms are detected slightly
more efficiently than basic ones in ELISA. In any case, 123I-
pLH like native LH is rapidly eliminated from blood and
scintigraphic imaging of its early distribution has permit-
ted to localize its initial route of elimination.
After injection of 123I-pLH, emission was located in the
stomach, intestine and thyroid only after 30 minutes p.i.
This indicates that free iodine due to deiodination of the
hormone, had no contribution during the initial 30-min
period.
The most prominent observation in this study was that
123I-pLH was trapped very rapidly and very efficiently at
the level of kidneys not the liver. Free 123I binding to
stomach, gut and thyroid after radiolabeled hormone
injections arose only after 30 min, much later than after
Na123I injection. Since these sites are known sites for
iodide binding [21], it is clear that the initial very fast
binding at the kidneys is not due to 123I from radiolabeled
pLH, but to the capture of 123I-pLH itself.
The rapid renal trapping of 123I-pLH observed in the
present study is at variance with the hypothesis that LH is
rapidly cleared from circulation by the sulfated-GalNAc-
GlcNac-Man receptors of hepatic reticuloendothelial cells
[4]. By contrast, our data are in agreement with previous
results [22] that showed an increase of the half-life of [3H-
methyl]ovine LH in nephrectomized rats relative to intact
rats. These authors also showed that LH accumulates in
the renal cortex after glomerular filtration and is reab-
sorbed by tubular epithelia, with subsequent lysosomal
catabolism. Half-life of LH had also been shown to
increase in castrated nephrectomized rats and sheep [5,6].
Altogether, our results and these data strongly support the
view that kidneys play a major role in the fast clearance of
Half-life of 123I-pLH and 123I-eCG in rats by scintigraphy Figure 4
Half-life of 123I-pLH and 123I-eCG in rats by scintigra-
phy. Quantitation of emission at the level of heart was used 
to follow residual concentrations of radioiodinated hor-
mones in blood. Half-life of 123I-pLH was determined by non-
linear regression of relative intensities as a function of time.Reproductive Biology and Endocrinology 2003, 1 http://www.RBEj.com/content/1/1/64
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LH. Interestingly, there was no significant transfer to urine
in the bladder, at least over the first hour after injection.
This puzzling observation suggests that LH is not simply
filtrated by the glomerulus but must be linked to some
binding sites. Bioactive forms of human LH and FSH are
found in large quantities in the urine of post-menopausal
women indicating that these gonadotropins are filtrated
in the kidneys and pass to urine without extensive degra-
dation. In this physiological situation, kidneys are faced
to long-lasting presence of a large concentration of hor-
mone and not to a single bolus of it. We thus suggest that
the binding sites for LH in the kidney become saturated in
post-menopausal women in the permanent presence of
large concentrations of LH. In the near future, we will test
this hypothesis in the rat model using the scintigraphic
approach described here.
No LH/CG receptors have been reported in the kidney, at
least in the human species [23]. Binding of 125I-oLH to
ovine kidney membrane fractions has been evidenced in
vitro  but, interestingly, it was not diminished in the
presence of a large excess of cold LH (Combarnous Y,
unpublished). Thus, this binding cannot be attributed to
saturable high-affinity receptors, but rather to low-affinity
high-capacity binding sites. Renotropic activity of oLH
[24,25] and pLH [26] has been reported and it has been
proposed that a carbohydrate moiety of these gonadotro-
pins containing a sulfate group is implicated in this activ-
ity [27]. For the time being, the presence of binding site
for sulfated carbohydrates has not been demonstrated in
the kidney.
In the case of 123I-eCG, the activities measured in the liver
and in the lungs were very similar. This indicates that the
hormone can be detected in blood in highly vascularized
organs without accumulation in a specific organ, explain-
ing its well-known long half-life. We didn't find noticea-
ble radioactivity in the genital tract for both hormones.
The number of LH/CG receptors is known to be only 20
000 per Leydig cell [28] which might be unsufficient for
efficient scintigraphic detection.
At the molecular level, it is now of interest to find out
what are the structural features of the LH molecule, not
present in eCG, that are responsible for its very fast trap-
ping by kidneys. Since the carbohydrate moieties of glyc-
oprotein hormones are known to play a prominent role in
their pharmacokinetic properties, it will be of particular
interest to perform a comparative scintigraphic study of
eCG and eLH elimination. Indeed these two hormones
are encoded by the same α and β genes and consequently
their α and β polypeptide chains are identical. However,
they are expressed in the pituitary or placenta respectively
and bear very different carbohydrate chains. It has already
been shown by Smith et al [29] that eLH has a much lower
half-life than eCG and possess sulphated carbohydrate
chains in contrast to eCG. These authors also found radi-
oactive eLH mainly in the liver at the end of the 30 min-
experiment but they did not study the kinetics of binding
to the different organs at shorter times. It would be very
interesting to see by scintigraphic imaging whether 123I-
eLH like 123I-pLH is rapidly trapped by kidneys before it is
by liver. Sulfated carbohydrate chains of pLH also bind to
the Macrophage Mannose Receptor (MMR) [30] found
not only in macrophages and dendritic cells but also in
hepatic endothelial cells and kidney mesangial cells. It is
thus of interest not only to determine the balance between
the hepatic and renal routes for the elimination of the dif-
ferent gonadotropins from plasma at different times after
injection but also to determine the respective roles of the
membrane lectins (Gal asialoglycoprotein receptor of
Ashwell, sulfated-GalNAc of Baenziger or MMR) involved
in this process.
Conclusions
In both the porcine and rat species, the liver is not respon-
sible for the rapid elimination of pLH from the circulation
(t1/2 ~3–6 min) compared to eCG (t1/2>5 h) In the rat,
123I-pLH is found to be rapidly trapped at the level of kid-
neys whereas 123I-eCG is not. Experiments in the two spe-
cies indicate that the very short circulatory half-life of LH
is due to rapid renal trapping and not to elimination by
the liver.
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